Browse hierarchy: [Radiology (RA)](/submissions/RA) → [Subpart B — Diagnostic Devices](/submissions/RA/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 892.1001](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/892.1001) → PCS — Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox

# PCS · Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox

_Radiology · 21 CFR 892.1001 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS

## Overview

- **Product Code:** PCS
- **Device Name:** Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox
- **Regulation:** [21 CFR 892.1001](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/892.1001)
- **Device Class:** 2
- **Review Panel:** [Radiology](/submissions/RA)

## Identification

The liver iron concentration imaging companion diagnostic for deferasirox is an image processing device intended to aid in the identification and monitoring of non-transfusion-dependent thalassemia patients receiving therapy with deferasirox. The device calculates a numeric value for liver iron concentration based on magnetic resonance images acquired under controlled conditions. The calculated numeric value is used to assess the need for deferasirox treatment and for monitoring treatment in patients with non-transfusion-dependent thalassemia. The liver iron concentration imaging companion diagnostic for deferasirox is essential to the safe and effective use of deferasirox in patients with non-transfusion-dependent thalassemia.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

In combination with the general controls of the FD&C Act, the Liver Iron Concentration Imaging Companion Diagnostic for Deferasirox is subject to the following special controls:

(1) Labeling must specify instructions for acceptance testing of images prior to processing.

(2) Labeling must specify data processing quality assurance protocols.

(3) Labeling must specify the sensitivity and specificity of liver iron concentration measurements.

(4) Nonclinical and clinical performance testing must be included in the premarket notification submission demonstrating the bias, precision, repeatability, and reproducibility of liver iron concentration measurements.

*Classification.* Class II (special controls). The special controls for this device are:(1) Design verification and validation must include nonclinical and clinical performance testing demonstrating the bias, precision, repeatability, and reproducibility of liver iron concentration measurements.
(2) Labeling must include specifying:
(i) Instructions for acceptance testing of images prior to processing;
(ii) Data processing quality assurance protocols; and
(iii) The sensitivity and specificity of liver iron concentration measurements.

## Recent Cleared Devices (3 of 3)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K213776](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS/K213776.md) | LiverSmart | Resonance Health Analysis Services Pty, Ltd. | Dec 29, 2021 | SESE |
| [K182218](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS/K182218.md) | FerriSmart Analysis System | Resonance Health Analysis Services Pty, Ltd. | Nov 30, 2018 | SESE |
| [DEN130012](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS/DEN130012.md) | FERRISCAN R2-MRI ANALYSIS SYSTEM | Resonance Health Analysis Services Pty, Ltd. | Jan 23, 2013 | DENG |

## Top Applicants

- Resonance Health Analysis Services Pty, Ltd. — 3 clearances

---

**Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/PCS)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com